- Filed
- May 5, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Capex | Q1 2022 · Mar 31, 2022 | $71.17M |
| Capex | Q1 2022 · Mar 31, 2021 | $34.76M |
| Long Term Debt | Q1 2022 · Mar 31, 2022 | $521.78M |
| Long Term Debt | Q1 2022 · Dec 31, 2021 | $601.25M |
| Short Term Debt | Q1 2022 · Mar 31, 2022 | $1.93M |
| Short Term Debt | Q1 2022 · Dec 31, 2021 | $4.13M |
| Cash And Equivalents | Q1 2022 · Mar 31, 2022 | $6.36M |
| Cash And Equivalents | Q1 2022 · Dec 31, 2021 | $23.68M |
| Stockholders Equity | Q1 2022 · Mar 31, 2022 | $314.03M |
| Stockholders Equity | Q1 2022 · Dec 31, 2021 | $323.53M |
| Current Liabilities | Q1 2022 · Mar 31, 2022 | $397.12M |
| Current Liabilities | Q1 2022 · Dec 31, 2021 | $268.88M |
| Current Assets | Q1 2022 · Mar 31, 2022 | $197.56M |
| Current Assets | Q1 2022 · Dec 31, 2021 | $186.15M |
| Total Assets | Q1 2022 · Mar 31, 2022 | $1.62B |
| Total Assets | Q1 2022 · Dec 31, 2021 | $1.58B |
| Net Income | Q1 2022 · Mar 31, 2022 | −$9.99M |
| Net Income | Q1 2022 · Mar 31, 2021 | −$13.57M |
| Cost Of Revenue | Q1 2022 · Mar 31, 2022 | $9.04M |
| Cost Of Revenue | Q1 2022 · Mar 31, 2021 | $4.67M |
| Shares Diluted | Q1 2022 · Mar 31, 2021 | 15.26M sh |
| Operating Cash Flow restated | Q1 2022 · Mar 31, 2021 | $32.69M |
| Eps Diluted | Q1 2022 · Mar 31, 2021 | −$0.89 |
| Eps Basic | Q1 2022 · Mar 31, 2021 | −$0.89 |
| Sga Expense | Q1 2022 · Mar 31, 2021 | $13.18M |
| Operating Income | Q1 2022 · Mar 31, 2021 | $30.67M |
| Revenue | Q1 2022 · Mar 31, 2021 | $88.56M |